Trial · NCT02460458
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Centralized Factor VIII (FVIII) Procoagulant Activity (FVIII:C) Laboratory Test for Type 3 Von Willebrand's Disease (VWD3) Diagnosis | Type 3 Von Willebrand's Disease (VWD3) | 2.42 | Standard Deviation 0.88 | IU/dL | |
| Centralized Von Willebrand Factor Antigen (VWF:Ag) Laboratory Test for Type 3 Von Willebrand's Disease (VWD3) Diagnosis | Type 3 Von Willebrand's Disease (VWD3) | 1.01 | Standard Deviation 1.03 | IU/dL | |
| Centralized Factor VIII (FVIII) Amidolytic Activity (FVIII:Am) Laboratory Test for Type 3 Von Willebrand's Disease (VWD3) Diagnosis | Type 3 Von Willebrand's Disease (VWD3) | 1.54 | Standard Deviation 0.91 | IU/dL | |
| Centralized Factor VIII (FVIII) Antigen (FVIII:Ag) Laboratory Test for Type 3 Von Willebrand's Disease (VWD3) Diagnosis | Type 3 Von Willebrand's Disease (VWD3) | 3.63 | Standard Deviation 0.83 | IU/dL | |
| Centralized Von Willebrand Factor (VWF) Multimer Analysis for Type 3 Von Willebrand's Disease (VWD3) Diagnosis | Type 3 Von Willebrand's Disease (VWD3) | Homozygotes | 174 | Participants | |
| Centralized Von Willebrand Factor (VWF) Multimer Analysis for Type 3 Von Willebrand's Disease (VWD3) Diagnosis | Type 3 Von Willebrand's Disease (VWD3) | Only Protomers | 15 | Participants | |
| Centralized Von Willebrand Factor (VWF) Multimer Analysis for Type 3 Von Willebrand's Disease (VWD3) Diagnosis | Type 3 Von Willebrand's Disease (VWD3) | 2 - 4 Bands | 54 | Participants | |
| Centralized Von Willebrand Factor (VWF) Propeptide Laboratory Test for Type 3 Von Willebrand's Disease (VWD3) Diagnosis | Type 3 Von Willebrand's Disease (VWD3) | 6.44 | Standard Deviation 13.98 | IU/dL | |
| Centralized Molecular Type 3 Von Willebrand's Disease (VWD3) Diagnosis Through DNA Analysis | Type 3 Von Willebrand's Disease (VWD3) | Analyzed participants with confirmed VWD3 diagnosis | 219 | Participants | |
| Centralized Molecular Type 3 Von Willebrand's Disease (VWD3) Diagnosis Through DNA Analysis | Type 3 Von Willebrand's Disease (VWD3) | Analyzed participants without confirmed VWD3 diagnosis | 12 | Participants | |
| Record of Bleeding Episodes | Type 3 Von Willebrand's Disease (VWD3) | 713 | bleeding episodes | ||
| Adverse Events | Type 3 Von Willebrand's Disease (VWD3) | 47 | AE | ||
| Type of Von Willebrand Factor / Factor VIII (VWF/FVIII)-Containing Concentrates in Use | Type 3 Von Willebrand's Disease (VWD3) | Recombinant Activated Factor FVIII | 1 | participants | |
| Type of Von Willebrand Factor / Factor VIII (VWF/FVIII)-Containing Concentrates in Use | Type 3 Von Willebrand's Disease (VWD3) | Fanhdi | 1 | participants | |
| Type of Von Willebrand Factor / Factor VIII (VWF/FVIII)-Containing Concentrates in Use | Type 3 Von Willebrand's Disease (VWD3) | Voncento/Haemate P | 33 | participants | |
| Type of Von Willebrand Factor / Factor VIII (VWF/FVIII)-Containing Concentrates in Use | Type 3 Von Willebrand's Disease (VWD3) | Wilate/Wilfactin (Wilfact) | 5 | participants | |
| Type of Von Willebrand Factor / Factor VIII (VWF/FVIII)-Containing Concentrates in Use | Type 3 Von Willebrand's Disease (VWD3) | Aryoseven | 1 | participants | |
| Patients Experiencing Allergic Reactions During Use of Von Willebrand Factor (VWF)-Containing Concentrates | Type 3 Von Willebrand's Disease (VWD3) | 41 | Participants | ||
| Number of Participants With Previous Use of Blood Products | Type 3 Von Willebrand's Disease (VWD3) | Packed red cells | 24 | Participants | |
| Number of Participants With Previous Use of Blood Products | Type 3 Von Willebrand's Disease (VWD3) | Cryoprecipitates | 123 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02460458/results